Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
American Journal of Cardiovascular Drugs
Journal
Overview
Identity
Overview
Publication Venue For
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
. 15:275-285.
2015
Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]
. 15:287.
2015
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
. 12:233-243.
2012
Triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: The trinity randomized, double-blind, 12-week, parallel-group study
. 12:233-243.
2012
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: Are we there yet?
. 12:1-6.
2012
Apolipoprotein E mimetics and cholesterol-lowering properties
. 11:371-381.
2011
Fixed-dose combinations in the management of hypertension: Defining the place of angiotensin receptor antagonists and hydrochlorothiazide
. 5:17-22.
2005
Strategies for minimizing hyperlipidemia after cardiac transplantation
. 2:377-387.
2002
Identity
International Standard Serial Number (issn)
1175-3277
Electronic International Standard Serial Number (eissn)
1179-187X